Partners Group Holding AG (SWX:PGHN) agreed to acquire majority stake in Pharmathen S.A. from BC Partners and Vnk Capital Ltd for an enterprise value of €1.6 billion on July 19, 2021. Partners Group on behalf of its clients acquired Pharmathen. BC Partners shall sell majority stake in Pharmathen. As part of transaction, Pharmathen's management team will be led by Chief Executive Officer Dimitris Kadis, on initiatives to scale the business in Europe and globally. The transaction is subject to receipt of customary regulatory approvals and is expected to close in 2021. Jefferies International Limited acted as financial advisor, Yi Duan, Lennard Keijzer, Etiënne Dijkhorst, of De Brauw Blackstone Westbroek N.V. and Kirkland & Ellis LLP acted as legal advisors for BC Partners. John Newton, Vicky McGrath, Albert Cacozza, Lincoln Tsang, Filko Prugo, Melissa Rones, Andrew Howard, Rohan Massey, Judith Seddon, and Paige Berges of Ropes & Gray acted as legal advisors for Partners Group. Andrew Boyd of Morrison & Foerster acted as legal advisor to Vnk Capital Ltd. Jennifer Storey of Clifford Chance acted as legal advisor for Partners Group. Karatzas & Partners, NKF and Weightmans acted as legal advisors in the transaction. Ernst & Young acted as due diligence provider to Partners Group.

Partners Group Holding AG (SWX:PGHN) completed the acquisition of Pharmathen S.A. from BC Partners and Vnk Capital Ltd in 2022